Lv6
2780 积分 2023-11-20 加入
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
14天前
已完结
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial
14天前
已完结
Explore ALK : Alectinib chez les patients atteints de cancer du poumon non à petites cellules métastatique ALK+: une analyse nationale en vie réelle (GFPC 03-2019)
21天前
已关闭
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
26天前
已完结
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer
26天前
已完结
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
1个月前
已完结
关节腔注射复方倍他米松注射液治疗膝骨关节炎疗效和安全性评价
2个月前
已完结
关节腔注射复方倍他米松注射液治疗膝骨关节炎疗效和安全性评价
2个月前
已关闭
皖公网安备34019202002308
